Myriad Genetics Will Present Results from Six Breast Cancer Studies at SABCS

Myriad Genetics Will Present Results from Six Breast Cancer Studies at SABCS

Myriad Genetics , Inc. , a leader in molecular diagnostics and personalized medicine, announced today that the Company will present six breast cancer studies at the 2016 San Antonio Breast Cancer Symposium being held Dec. 6-10, 2016 in San Antonio, Texas. "Myriad Genetics is proud to offer the highest-quality molecular diagnostic tests designed to help prevent breast cancer and improve health outcomes for those with breast cancer," said Johnathan Lancaster, M.D., Ph.D., chief medical officer, Myriad Genetic Laboratories.

from Biotech News